1.
Batu ED, Ozen S. Pediatric vasculitis. Curr Rheumatol Rep 2012;14: 121-9.
2.
López-Mejías R, Castañeda S, Genre F, et al. Genetics ofimmunoglobulin-A vasculitis (Henoch-Schönlein purpura): Anupdated review. Autoimmun Rev 2018; 17: 301-15.
3.
Ekinci RMK, Balci S, Bisgin A, et al. MEFV gene variants inchildren with Henoch-Schönlein purpura and association withclinical manifestations: a single-center Mediterranean experience.Postgrad Med 2019; 131: 68-72.
4.
Peru H, Soylemezoglu O, Bakkaloglu SA, et al. Henoch Schonleinpurpura in childhood: clinical analysis of 254 cases over a 3-yearperiod. Clin Rheumatol 2008; 27: 1087-92.
5.
Trapani S, Micheli A, Grisolia F, et al. Henoch Schonlein purpurain childhood: epidemiological and clinical analysis of 150 casesover a 5-year period and review of literature. Semin ArthritisRheum 2005; 35: 143-53.
6.
Coppo R, Andrulli S, Amore A, et al. Predictors of outcome inHenoch-Schönlein nephritis in children and adults. Am J KidneyDis 2006; 47: 993-1003.
7.
Hocevar A, Rotar Z, Ostrovršnik J,et al. Incidence of IgAvasculitis in the adult Slovenian population. Br J Dermatol 2014;171: 524-7.
8.
Shin JI, Kim JH, Lee JS, Kim DS, Choi JY, Sul JH. Cardiacmanifestations of Henoch-Schoenlein purpura: IgA mediatedvasculitis or rheumatic fever? Eur J Pediatr 2007; 166: 627.
9.
Cai J, Wang K, Han T, Jiang H. Evaluation of prognostic valuesof inflammation-based makers in patients with HBV-relatedacute-on-chronic liver failure. Medicine (Baltimore) 2018; 97:13324.
10.
Park CH, Han DS, Jeong JY, et al. The optimal cut-off value ofneutrophil-to-lymphocyte ratio for predicting prognosis in adultpatients with Henoch-Schönlein purpura. PLoS One 2016; 11:0153238.
11.
Feng JF, Huang Y, Chen QX. Preoperative platelet lymphocyteratio (PLR) is superior to neutrophil lymphocyte ratio (NLR)as a predictive factor in patients with esophageal squamous cellcarcinoma. World J Surg Oncol 2014; 12: 58.
12.
Yang R, Chang Q, Meng X, Gao N, Wang W. Prognostic valueof Systemic immune-inflammation index in cancer: A meta-analysis. J Cancer 2018 7; 9: 3295-302.
13.
Wu J, Yan L, Chai K. Systemic immune-inflammation indexis associated with disease activity in patients with ankylosingspondylitis. J Clin Lab Anal 2021; 35: 23964.
14.
Yorulmaz A, Hayran Y, Akpinar U, et al. Systemic immune-inflammation index (SII) predicts increased severity in psoriasisand psoriatic arthritis. Curr Health Sci J 2020; 46: 352-7.
15.
Chen JB, Tang R, Zhong Y, et al. Systemic immune-inflammationindex predicts a reduced risk of end-stage renal disease in Chinesepatients with myeloperoxidase-anti-neutrophil cytoplasmicantibody-associated vasculitis: A retrospective observationalstudy. Exp Ther Med 2021; 22: 989.
16.
Lapic I, Padoan A, Bozzato D, Plebani M. ErythrocyteSedimentation Rate and C-Reactive Protein in AcuteInflammation. Am J Clin Pathol 2020; 153: 14-29.
17.
Don BR, Kaysen G. Serum albumin: relationship to inflammationand nutrition. Semin Dial 2004; 17: 432-7.
18.
Fairclough E, Cairns E, Hamilton J, Kelly C. Evaluation of amodified early warning system for acute medical admissions andcomparison with C-reactive protein/albumin ratio as a predictorof patient outcome. Clin Med (Lond) 2009; 9: 30-3
19.
Kinoshita A, Onoda H, Imai N, et al. The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score,predicts outcomes in patients with hepatocellular carcinoma. AnnSurg Oncol 2015; 22: 803-10.
20.
Moon JS, Ahn SS, Park YB, Lee SK, Lee SW. C-reactive proteinto serum albumin ratio is an independent predictor of all-causemortality in patients with ANCA-associated vasculitis. YonseiMed J 2018; 59: 865-71.
21.
Tanacan E, Dincer D, Erdogan FG, Gurler A. A cutoff value for theSystemic Immune-Inflammation Index in determining activity ofBehçet disease. Clin Exp Dermatol 2021; 46: 286-91.
22.
Prais D, Amir J, Nussinovitch M. Recurrent Henoch-Schonleinpurpura in children. J Clin Rheumatol 2007; 13: 25-8.
23.
Ozen S, Pistorio A, Iusan SM, et al. EULAR/PRINTO/PREScriteria for Henoch-Schönlein purpura, childhood polyarteritisnodosa, childhood Wegener granulomatosis and childhoodTakayasu arteritis: Ankara 2008. Part II: Final classificationcriteria. Ann Rheum Dis 2010; 69: 798-806.
24.
Du L, Wang P, Liu C, Li S, Yue S, Yang Y. Multisystemicmanifestations of IgA vasculitis. Clin Rheumatol 2021; 40: 43-52.
25.
Fu W, Ye W, Liu X, et al. Meta-analysis of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in Henoch-Schonlein purpura and its complications. Int Immunopharmacol2021; 94: 107454.
26.
Leung AKC, Barankin B, Leong KF. Henoch-Schönlein purpurain children: an updated review. Curr Pediatr Rev 2020; 16: 265-76.
27.
Chen JH, Zhai ET, Yuan YJ, et al. Systemic immune-inflammationindex for predicting prognosis of colorectal cancer. World JGastroenterol 2017; 23: 6261-72.
28.
Tian Y, Liu N, Yin H, Duan L. Relationship between C-reactiveprotein/serum albumin ratio, neutrophil/lymphocyte ratio, andANCA-associated vasculitis activity: a retrospective single centercohort study. Front Med (Lausanne) 2022; 9: 855869.
29.
Kim Y, Choi H, Jung SM, Song JJ, Park YB, Lee SW. Systemicimmune-inflammation index could estimate the cross-sectionalhigh activity and the poor outcomes in immunosuppressivedrug-naïve patients with antineutrophil cytoplasmic antibody-associated vasculitis. Nephrology (Carlton) 2019; 24: 711-7.
30.
Ozen S. The spectrum of vasculitis in children. Best Pract Res ClinRheumatol 2002; 16: 411-25.
31.
Chen SY, Kong MS. Gastrointestinal manifestations andcomplications of Henoch-Schönlein purpura. Chang Gung MedJ 2004; 27: 175-81.
32.
Tabel Y, Inanc FC, Dogan DG, Elmas AT. Clinical features ofchildren with Henoch-Schonlein purpura: risk factors associatedwith renal involvement. Iran J Kidney Dis 2012; 6: 269-74.
33.
Chan H, Tang YL, Lv XH, et al. Risk Factors Associated withRenal Involvement in Childhood Henoch-Schönlein Purpura: AMeta-Analysis. PLoS One 2016: 30; 11: e0167346.
34.
Uppal SS, Hussain MA, Al-Raqum HA, et al. Henoch-Schönlein'spurpura in adults versus children/adolescents: A comparativestudy. Clin Exp Rheumatol 2006; 24: 26-30.
35.
Fretzayas A, Sionti I, Moustaki M, Papadimitriou A, NicolaidouP. Henoch-Schönlein purpura: a long-term prospective study inGreek children. J Clin Rheumatol 2008; 14: 324-31.
36.
Karadağ ŞG, Tanatar A, Sönmez HE, et al. The clinical spectrumof Henoch-Schönlein purpura in children: a single-center study.Clin Rheumatol 2019; 38: 1707-14.
37.
Calvo-Río V, Hernández JL, Ortiz-Sanjuán F, et al. Relapses inpatients with Henoch-Schönlein purpura: Analysis of 417 patientsfrom a single center. Medicine (Baltimore) 2016; 95: 4217.
38.
Demirtaş Ş, Dursun İ, Pınarbaşı AS, et al. The Factors Affecting theOccurrence of Renal Involvement in Children with IgA Vasculitis:Renal Involvement of IgA Vasculitis. J Pediatr Acad 2020; 1: 50-5.
39.
Bogdanovic R. Henoch-Schönlein purpura nephritis in children:risk factors, prevention and treatment. Acta Paediatr 2009; 98:1882-9.
40.
Sano H, Izumida M, Shimizu H, Ogawa Y. Risk factors of renalinvolvement and significant proteinuria in Henoch-Schönleinpurpura. Eur J Pediatr 2002; 161: 196-201.
41.
Assulyn T, Khamisy-Farah R, Nseir W, Bashkin A, Farah R.Neutrophil-to-lymphocyte ratio and red blood cell distributionwidth as predictors of microalbuminuria in type 2 diabetes. J ClinLab Anal 2020; 34: 23259.
42.
Navegantes KC, de Souza Gomes R, Pereira PAT, Czaikoski PG,Azevedo CHM, Monteiro MC. Immune modulation of someautoimmune diseases: the critical role of macrophages andneutrophils in the innate and adaptive immunity. J Transl Med2017; 15: 36.
43.
Barut K, Sahin S, Kasapcopur O. Pediatric vasculitis. Curr OpinRheumatol 2016; 28: 29-38.
44.
Özdemir ZC, Çetin N, Kar YD, Öcal HO, Bilgin M, Bör Ö.Hemotologic indices for predicting internal organ involvementin Henoch-Schönlein purpura (IgA vasculitis). J Pediatr HematolOncol 2020; 42: 46-49.
45.
Jagroop IA, Clatworthy I, Lewin J, Mikhailidis DP. Shape changein human platelets: measurement with a channelyzer andvisualisation by electron microscopy. Platelets 2000; 11: 28-32.
46.
Edström Halling S, Söderberg MP, Berg UB. Predictors of outcomein Henoch-Schönlein nephritis. Pediatr Nephrol 2010; 25: 1101-8.
47.
Yang YL, Wu CH, Hsu PF, et al. Systemic immune-inflammationindex (SII) predicted clinical outcome in patients with coronaryartery disease. Eur J Clin Invest 2020; 50: 13230.
48.
Fois AG, Paliogiannis P, Scano V, et al. The systemicınflammation ındex on admission predicts ın-hospital mortalityin COVID-19 patients. Molecules 2020; 25: 5725. doi: 10.3390/molecules25235725.
49.
Güneylioğlu MM, Güngör A, Göktuğ A, et al. Evaluation ofthe efficiency of the systemic immune-inflammation index indifferentiating parapneumonic effusion from empyema. PediatrPulmonol 2022; 57: 1625-30.
50.
Ranzani OT, Zampieri FG, Forte DN, Azevedo LC, Park M.C-reactive protein/albumin ratio predicts 90-day mortality ofseptic patients. PLoS One 2013; 8: 59321.
51.
Chen JH, Zhai ET, Yuan YJ, et al. Systemic immune-inflammationindex for predicting prognosis of colorectal cancer. World JGastroenterol 2017; 23: 6261-72.